nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
2025 American Thoracic Society International Conference
|
Venkatesan, Priya |
|
|
13 |
8 |
p. e43-e44 |
artikel |
2 |
Asthma: epidemiology, risk factors, and opportunities for prevention and treatment
|
Jayasooriya, Shamanthi M |
|
|
13 |
8 |
p. 725-738 |
artikel |
3 |
Breathing barriers: bridging lung health, research, and awareness
|
Pott, Hendrik |
|
|
13 |
8 |
p. 665-667 |
artikel |
4 |
Correction to Lancet Respir Med 2025; 13: e39–40
|
|
|
|
13 |
8 |
p. e38 |
artikel |
5 |
Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial
|
Shi, Yuankai |
|
|
13 |
8 |
p. 677-686 |
artikel |
6 |
Embracing the challenges in asthma care through innovation
|
The Lancet Respiratory Medicine, |
|
|
13 |
8 |
p. 655 |
artikel |
7 |
Everything is Tuberculosis
|
Burki, Talha |
|
|
13 |
8 |
p. 674-675 |
artikel |
8 |
First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study
|
Garriga-Grimau, Laura |
|
|
13 |
8 |
p. 698-708 |
artikel |
9 |
2025 GINA report for asthma
|
Venkatesan, Priya |
|
|
13 |
8 |
p. e41-e42 |
artikel |
10 |
Global epidemiology and burden of interstitial lung disease
|
Spagnolo, Paolo |
|
|
13 |
8 |
p. 739-755 |
artikel |
11 |
Integrated care for tuberculosis and lung health
|
González-Angulo, Lice |
|
|
13 |
8 |
p. 667-669 |
artikel |
12 |
Joan B Soriano—expert on asthma, COPD, and long COVID
|
Kirby, Tony |
|
|
13 |
8 |
p. 672-673 |
artikel |
13 |
Limertinib for EGFR mutation-positive NSCLC treatment
|
Xia, Yang |
|
|
13 |
8 |
p. 656-657 |
artikel |
14 |
No plan B, no planet B: confronting the rising global burden of chronic respiratory diseases
|
Soriano, Joan B |
|
|
13 |
8 |
p. 661-662 |
artikel |
15 |
Opportunities and challenges of COPD tertiary prevention
|
Slok, Annerika H M |
|
|
13 |
8 |
p. 662-664 |
artikel |
16 |
Policy view: worldwide patterns of tobacco use with recommendations for tobacco control
|
McHardy, Juliette |
|
|
13 |
8 |
p. 756-768 |
artikel |
17 |
The carbon footprint of inhaled medications in Australia
|
Venkatesan, Priya |
|
|
13 |
8 |
p. e39-e40 |
artikel |
18 |
The global burden of COPD: epidemiology and effect of prevention strategies
|
de Oca, Maria Montes |
|
|
13 |
8 |
p. 709-724 |
artikel |
19 |
The power of paediatric bronchiectasis health registries
|
Byrnes, Catherine A |
|
|
13 |
8 |
p. 659-661 |
artikel |
20 |
Transforming COPD management: the role of dupilumab
|
Çolak, Yunus |
|
|
13 |
8 |
p. 657-659 |
artikel |
21 |
Tuberculosis in Indonesia: challenges and future directions
|
Saktiawati, Antonia Morita Iswari |
|
|
13 |
8 |
p. 669-671 |
artikel |
22 |
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
|
Christenson, Stephanie A |
|
|
13 |
8 |
p. 687-697 |
artikel |
23 |
US EPA to scrap stronger air pollution limits for power plants
|
Furlow, Bryant |
|
|
13 |
8 |
p. 676 |
artikel |
24 |
Why it's more than “just a cough”
|
Ranscombe, Peter |
|
|
13 |
8 |
p. 673-674 |
artikel |